Director HTA & Decision Science

Johnson & Johnson•Raritan, NJ

1d•Hybrid

About The Position

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Johnson & Johnson Innovative Medicine (JJIM) is currently recruiting for a Director, Health Technology Assessment & Decision Science (HTA & DS), within the Global Commercial Strategy Organization (GCSO), to be located in Raritan, NJ or Beerse, Belgium. The Director, Health Technology Assessment & Decision Science (HTA & DS) plays a critical role in informing and shaping internal decision making on our clinical development programs, complementary evidence generation and market access strategies across the J&J Innovative Medicine portfolio, supporting timely global market access, reimbursement and coverage. The role sits within the Global Commercial Strategy Organization’s Market Access Center of Excellence and partners closely with Therapy Area and Regional Market Access, R&D, Regulatory, and other cross‑functional teams worldwide.

Requirements

Advanced degree (MSc, PhD, PharmD, MD, or equivalent) in a relevant discipline (eg., Epidemiology, Biostatistics, (health) Economics, HTA, Medicine, Public Health).
At least 7 years of experience in HTA, market access, evidence generation, or related fields, in a pharmaceutical organization and/or external agency.
Strong R&D acumen
Experience working across multiple therapeutic areas (ideally including one or more of Oncology, Immunology, Neuroscience, Cardiopulmonary) and phase 2, 3 development and launch phases.
Strong understanding of international health care, HTA, payer and regulatory environments, with one or more of Europe, the US, and Japan preferred.
Global mindset with proven ability to lead, influence, and collaborate across diverse global, cross‑functional teams.
Strong strategy development capabilities with the ability to understand, synthesize and translate complex evidence into scenario planning and actionable directions.
Advanced analytical and critical thinking skills.
Intellectual curiosity and creativity to challenge existing approaches and develop innovative solutions.
Clear, confident communicator (verbal and written).
Ability to plan, prioritize, and deliver work effectively in a highly matrixed environment with competing demands.
Demonstrated commitment to continuous learning and capability development.

Nice To Haves

Agility Jumps
Commercial Awareness
Competitive Landscape Analysis
Cross-Functional Collaboration
Customer Intelligence
Global Market
Go-to-Market Strategies
Health Economics
Health Intelligence
Market Knowledge
Market Opportunity Assessment
Mentorship
Pricing Strategies
Regulatory Compliance
Strategic Change
Tactical Planning
Technical Credibility

Responsibilities

Inform and support internal decision making at internal stage gate, governance meetings and functional advisory meetings by translating HTA agency, payer and health system insights and benchmarks for key markets (incl. US, Japan, EU G4, UK) into actionable decision‑science inputs for development programs and access & evidence generation strategies.
Leverage generative AI to enable and enhance internal decision making.
Leading, supporting and delivering early HTA agency advice activities, including individual agency and multi-agency procedures (e.g. EU Joint Scientific Consultations) across the portfolio, in collaboration with product teams.
Represent HTA & DS in EU Joint Clinical Assessment (EU JCA) dossier teams, shaping and contributing to delivering PICO strategy and informing dossier development strategy.
Ensure cross-program consistency and sharing of key lessons learned.
Provide Market Access technical and scientific review at Protocol Review Committee to ensure patient‑ and payer‑relevant study designs.
Contribute to and deliver HTA capability development, internal briefings, external positioning documents, and external thought leadership.
Serve as an HTA & DS expert for product teams, providing strategic guidance on HTA agency/ payer requirements, and drive organizational learning.

Benefits

consolidated retirement plan (pension)
savings plan (401(k))
long-term incentive program
Vacation –120 hours per calendar year
Sick time - 40 hours per calendar year
Holiday pay, including Floating Holidays –13 days per calendar year
Work, Personal and Family Time - up to 40 hours per calendar year
Parental Leave – 480 hours within one year of the birth/adoption/foster care of a child
Bereavement Leave – 240 hours for an immediate family member: 40 hours for an extended family member per calendar year
Caregiver Leave – 80 hours in a 52-week rolling period
Volunteer Leave – 32 hours per calendar year
Military Spouse Time-Off – 80 hours per calendar year